International Clinical Trial: Evaluation of the immunogenicity and safety of a freeze-dried human rabies vaccine (human diploid cells) administered by different immunization regimens in a phase III randomized, blinded, and active-controlled trial in 10-60 year old subjects

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119349) titled 'Evaluation of the immunogenicity and safety of a freeze-dried human rabies vaccine (human diploid cells) administered by different immunization regimens in a phase III randomized, blinded, and active-controlled trial in 10-60 year old subjects' on Feb. 26.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Hubei Provincial Center for Disease Control and Prevention

Condition: Rabies

Intervention: Essen control group:Vaccination with control vaccine on 0, 3, 7, 14, 28 days Zagreb test group:Get experimental vaccines on 0 (first 2 doses), 7, and 21 days (1 dose each) Four simple doses-g...